Skip to content

Drug interactions

Natalizumab + Vedolizumab

Severity: Contraindicated

Natalizumab and Vedolizumab: contraindicated interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Both drugs block integrin-mediated lymphocyte trafficking, natalizumab broadly including the CNS and vedolizumab selectively in the gut. Combined use may raise the risk of PML and other infections.

What this interaction means in plain words

Natalizumab and Vedolizumab are not normally used together. Taking them at the same time is expected to cause harm or make one of them unsafe, so a different medicine is usually chosen for one of the two.

Natalizumab belongs to Gastrointestinal Tract; Vedolizumab belongs to Gastrointestinal Tract.

Evidence level: Moderate

Why it happens

Overlapping integrin antagonism causing additive impairment of lymphocyte trafficking.

What to do

Do not use together. If switching, stop one agent before starting the other and monitor for infection and neurological symptoms.

What to ask your pharmacist

  • Is there an alternative to one of these two medicines for me?
  • If both are essential, who is monitoring me and how often?
  • Which symptoms mean I should stop and seek help straight away?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Natalizumab and Vedolizumab, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 14 days on the web. No card needed.

Frequently asked questions

Can I take Natalizumab with Vedolizumab?

MediHelp rates the interaction as contraindicated. Natalizumab and Vedolizumab are not normally used together. Taking them at the same time is expected to cause harm or make one of them unsafe, so a different medicine is usually chosen for one of the two. Both drugs block integrin-mediated lymphocyte trafficking, natalizumab broadly including the CNS and vedolizumab selectively in the gut. Combined use may raise the risk of PML and other infections.

How serious is the interaction between Natalizumab and Vedolizumab?

MediHelp rates it contraindicated, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Do not use together. If switching, stop one agent before starting the other and monitor for infection and neurological symptoms.

What other medicines interact with Natalizumab?

MediHelp also lists interactions of Natalizumab with, for example, Axicabtagene ciloleucel, Baricitinib, Belatacept. The full list is on the Natalizumab page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in